Heart failure in the diabetic population - pathophysiology, diagnosis and management. - Wikidata - awgldk - TriplyDB

Heart failure in the diabetic population - pathophysiology, diagnosis and management.

Heart failure in the diabetic population - pathophysiology, diagnosis and management.

http://www.wikidata.org/entity/Q33935375

about

Risk for Incident Heart Failure: A Subject-Level Meta-Analysis From the Heart "OMics" in AGEing (HOMAGE) Study.Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy.Prevalence and risk factors of heart failure in the USA: NHANES 2013 - 2014 epidemiological follow-up study.The importance of two metabolic syndrome diagnostic criteria and body fat distribution in predicting clinical severity and prognosis of acute myocardial infarction.Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.Influence of home-based telemonitored Nordic walking training on autonomic nervous system balance in heart failure patients.Exercise Training Attenuates Upregulation of p47(phox) and p67(phox) in Hearts of Diabetic Rats Can the onset of heart failure be delayed by treating diabetic cardiomyopathy?Sulfonylureas and their use in clinical practice.Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure.Tropisetron inhibits high glucose-induced calcineurin/NFAT hypertrophic pathway in H9c2 myocardial cells.Natriuretic Peptide System Activation in Acute Heart Failure Patients with Diabetes Tissue Doppler assessment of left ventricular function in asymptomatic diabetic patients.The Evaluation of a Low-Cost Colorimeter for Glucose Detection in Salivary Samples.Linking temporal medical records using non-protected health information data.Type-2 diabetic aldehyde dehydrogenase 2 mutant mice (ALDH 2*2) exhibiting heart failure with preserved ejection fraction phenotype can be determined by exercise stress echocardiography.Commentary on "Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus: International Task Force".

P2860

Q30234586-5698A86E-CB1C-4433-96D9-C2EBDAF73D29 Q33645941-1583A802-674E-40FE-A2D8-72BE0CF6CE4F Q33777255-EB7472BC-5370-4032-AE23-DDB58A106344 Q33904430-9F462091-7F5D-4257-80B6-537474498CA7 Q36219006-836FA482-B277-4300-946D-8E53384107A3 Q36418996-B3163DD0-F586-41D0-8667-C28D04D93CBE Q36632902-2B489E2D-F820-4686-B376-C3C796A9982C Q37737932-96793503-C292-4D66-8FB0-008C0C772436 Q38577058-48867E25-04A3-46B0-9139-2B3ACDAAEA2C Q38604382-36DBC9AB-8A4A-4601-8A66-C96A00DB68F2 Q38788707-035CA3F3-1B4E-420B-8722-4F1B94803D77 Q41448269-65550BBC-1ABA-417A-A164-8F20CD01C2CC Q42339250-69DBFDC4-ECE6-4F22-AF1B-ED67DBBBACC5 Q47099392-85A80EDB-A1D7-4A55-B785-4004140C969F Q47213646-1BD7792C-D8D2-49C8-9F1E-6BA5916C1216 Q55014723-46AF6A35-441D-48C0-8F84-FD7E62173CA0 Q55344735-9DD38214-916C-419F-AE79-61EC7D4D6BFC

P2860

Heart failure in the diabetic population - pathophysiology, diagnosis and management.

http://www.wikidata.org/entity/Q33935375

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Heart failure in the diabetic population - pathophysiology, diagnosis and management.

@ast

Heart failure in the diabetic population - pathophysiology, diagnosis and management.

@en

type

label

Heart failure in the diabetic population - pathophysiology, diagnosis and management.

@ast

Heart failure in the diabetic population - pathophysiology, diagnosis and management.

@en

prefLabel

Heart failure in the diabetic population - pathophysiology, diagnosis and management.

@ast

Heart failure in the diabetic population - pathophysiology, diagnosis and management.

@en

P1433

Q33935375-961DBD5A-E2BE-446E-8DCE-4D3BB41DEE22

P1476

Q33935375-8B77F912-D069-4896-B564-6B3E98055A52

P2093

Q33935375-4B6BFFF8-D075-4D69-BB2F-F08EA35777CF

P2860

Q33935375-0072F6E1-D924-43F2-8191-CE28FBBCBEC2

Q33935375-019C34A7-A125-4B3B-911A-D68237C38B6A

Q33935375-06E5DAD7-00CE-4B59-A257-6FF4C036667D

Q33935375-07484350-9CB9-4225-A99A-2484624AE815

Q33935375-0B70F570-C7D3-4DE6-9A7A-817AA59DF20D

Q33935375-0F303E90-CDF4-4BB3-AC81-C70B61089EF1

Q33935375-1192E343-D682-4AC6-B320-A107D13631C4

Q33935375-123A2E56-612D-46AF-8B4F-6802DD97E057

Q33935375-13727ACB-DD9C-423D-8510-A2221A73F5B4

Q33935375-14E57F73-E52A-4190-8FA1-414FD28C4EDF

P304

Q33935375-2ABA39AC-6170-4515-8072-9A696705A7CF

P31

Q33935375-877D50EF-B963-4F48-904E-94E45DB6A6F5

P356

Q33935375-DB5B2455-5871-4FC4-9DCA-28CA58D84306

P433

Q33935375-22A9F611-5AC9-4F78-85BD-EA3F7363D353

P478

Q33935375-76A0575F-330B-42D0-9570-FF0D141A9431

P50

Q33935375-5E46D5AA-2885-4194-8AAB-3765A2AE8337

P577

Q33935375-7D34A49D-91A9-41A2-A56C-CDFD1C37CB24

P5875

Q33935375-C4C58F9C-01EE-4AF1-9473-C2FCFC929B8F

P698

Q33935375-B0AC3E3B-24C4-47B2-865F-892424EB17B6

P921

Q33935375-045329AF-20C3-4B6D-8D88-AFBB0164092B

Q33935375-B2ED2B1E-8DAF-42A8-B5DD-AF028C09F52E

P932

Q33935375-C1A24BC7-CC40-4131-88F6-56703833D806

P356

AOMS.2014.43748

P1433

Archives of Medical Science

P1476

Heart failure in the diabetic population - pathophysiology, diagnosis and management.

@en

P2093

Jacek Kasznicki

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

The pathobiology of diabetic complications: a unifying mechanism

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells.

The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes.

P304

546-556

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/AOMS.2014.43748

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Józef Drzewoski

P577

2014-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264537845

http://www.w3.org/2001/XMLSchema#string

P698

25097587

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

P932

4107260

http://www.w3.org/2001/XMLSchema#string